TRACEY ROYER: Open Payments
NPI 1225401227 · WHITE PLAINS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,621 in 107 payments from 39 companies in 2025. Trend: 2023 $4,437 · 2024 $4,437 · 2025 $3,621
Food & beverage: $2,588Long term medical supply or device loan: $1,033
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $1,179 |
| Janssen Biotech, Inc. | 10 | $261 |
| Merck Sharp & Dohme LLC | 8 | $206 |
| Stemline Therapeutics Inc. | 2 | $152 |
| SOBI, INC | 4 | $123 |
| AstraZeneca Pharmaceuticals LP | 4 | $113 |
| PFIZER INC. | 4 | $110 |
| ABBVIE INC. | 3 | $90 |
| GlaxoSmithKline, LLC. | 3 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
Products named: KISQALI, KEYTRUDA, Orserdu, Vonjo, TECVAYLI, Nubeqa, DARZALEX, MI CANCER SEEK.
Industry payments across MD — which companies pay providers there.
